LASILIX RETARD 60 mg, gélule — tube(s) polypropylène de 30 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400932492374
  • CIP7 3249237
  • CIS 67131583

What the source publishes

Holder
SANOFI WINTHROP INDUSTRIE
Active ingredients
FUROSÉMIDE
Form
gélule
Package
tube(s) polypropylène de 30 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
liste II
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
1981-07-31
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400932492374
{
  "cis": "67131583",
  "cip7": "3249237",
  "form": "gélule",
  "name": "LASILIX RETARD 60 mg, gélule — tube(s) polypropylène de 30 gélule(s)",
  "cip13": "3400932492374",
  "holder": "SANOFI WINTHROP INDUSTRIE",
  "routes": [
    "orale"
  ],
  "holders": [
    "SANOFI WINTHROP INDUSTRIE"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "4.73",
  "authorisedOn": "1981-07-31",
  "compositions": [
    {
      "name": "FUROSÉMIDE",
      "nature": "SA",
      "strength": "60 mg",
      "linkageNumber": "1",
      "substanceCode": "01958",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste II",
  "dispensingFee": "1.02",
  "medicinePrice": "3.71",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LASILIX RETARD 60 mg, gélule",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "tube(s) polypropylène de 30 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2025-09-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "FUROSÉMIDE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste II"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400932492374"